This page contains a Flash digital edition of a book.
ANALYTICAL AND LABORATORY EQUIPMENT 29


Analysis of mycotoxins in grains


Brian Kinsella explores a method to prepare samples using polymeric SPE and LC-MS-MS.


M ycotoxins are


naturally occurring secondary metabolites


produced by several species of fungi. Tey pose a health risk to humans and animals due to their harmful biological properties and common occurrence in food and feed. Analysis of mycotoxins is challenging due to their large number and varied physicochemical properties. Additionally, the food samples tested are complex in nature and are often contaminated with several mycotoxins at low concentrations.


Fig. 1. SRM Transitions.


Tis application details a method for the sample preparation of grain-based food via polymeric SPE and analysis by LC-MS/ MS. HPLC separation of 16 mycotoxins and three internal standards was successfully conducted in < 16 minutes using a Selectra DA column – 100 × 2.1mm, 3 µm from UCT. Tis


polyaromatic column provides greater retention of the polar trichothecenes as compared to a C18 column. Compounds included are representative of a wide range of mycotoxins, including type A- and B-trichothecenes, ochratoxin A, alternariol, zearalenone, α- & β-zearalanol and aflatoxins.


2g of sample was hydrated with 2ml of DI water (≥15 min). 10ml of ACN was added to each sample and vortex mixed for 10 minutes followed by centrifugation for 10 minutes (≥3,000 × g, 4°C). Te supernatant was transferred to a clean glass tube and evaporated to dryness at 50°C under a gentle stream of nitrogen. 10ml of DI water was added to each sample and vortex mixed.


SPE procedure Polymeric SPE cartridges (EnviroClean HL DVB 200 mg/6ml cartridge from UCT)


were conditioned with 3ml MeOH and 3ml DI water. Te sample supernatants were loaded onto each cartridge and allowed to percolate through the cartridges under gravity. Te cartridges were then washed sequentially with 3ml of DI water followed by 3ml of 10% MeOH. Te cartridges were dried under vacuum for 10 minutes (≥10 inHg). Ten 3ml of hexane was added to each cartridge and slowly drawn through. Te cartridges were dried under vacuum (≥10 inHg) for five minutes. Te mycotoxins were eluted from the SPE cartridges using 4ml ACN. Te extracts were evaporated to dryness at 40°C under a gentle stream of nitrogen, then reconstituted in 1ml of MeOH:H2


O (50:50, v/v).


Te instrumentation used for this experiment was a Termo Scientific Dionex Ultimate 3000 LC system coupled to a Termo Scientific TSQ Vantage tandem mass spectrometer. Various LC-MS/MS conditions were examined prior to settling on the use of APCI ionisation and MeOH/ammonium formate (10mm) as the mobile phase. Tis set-up provided the best combination to effectively detect and quantitate all the mycotoxins. Parameters investigated included ESI versus APCI; ACN versus MeOH as the organic solvent, as well as a variety of mobile phase buffers.


Owing to their polarity, type-B trichothecenes typically elute early in chromatographic runs, and are known to be prone to matrix effects in the ion source. To reduce this possibility a Selectra DA column containing a polyaromatic phase was


www.scientistlive.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120